2.Application and evaluation of artificial intelligence TPS-assisted cytologic screening system in urine exfoliative cytology.
L ZHU ; M L JIN ; S R HE ; H M XU ; J W HUANG ; L F KONG ; D H LI ; J X HU ; X Y WANG ; Y W JIN ; H HE ; X Y WANG ; Y Y SONG ; X Q WANG ; Z M YANG ; A X HU
Chinese Journal of Pathology 2023;52(12):1223-1229
Objective: To explore the application of manual screening collaborated with the Artificial Intelligence TPS-Assisted Cytologic Screening System in urinary exfoliative cytology and its clinical values. Methods: A total of 3 033 urine exfoliated cytology samples were collected at the Henan People's Hospital, Capital Medical University, Beijing, China. Liquid-based thin-layer cytology was prepared. The slides were manually read under the microscope and digitally presented using a scanner. The intelligent identification and analysis were carried out using an artificial intelligence TPS assisted screening system. The Paris Report Classification System of Urinary Exfoliated Cytology 2022 was used as the evaluation standard. Atypical urothelial cells and even higher grade lesions were considered as positive when evaluating the recognition sensitivity, specificity, and diagnostic accuracy of artificial intelligence-assisted screening systems and human-machine collaborative cytologic screening methods in urine exfoliative cytology. Among the collected cases, there were also 1 100 pathological tissue controls. Results: The accuracy, sensitivity and specificity of the AI-assisted cytologic screening system were 77.18%, 90.79% and 69.49%; those of human-machine coordination method were 92.89%, 99.63% and 89.09%, respectively. Compared with the histopathological results, the accuracy, sensitivity and specificity of manual reading were 79.82%, 74.20% and 95.80%, respectively, while those of AI-assisted cytologic screening system were 93.45%, 93.73% and 92.66%, respectively. The accuracy, sensitivity and specificity of human-machine coordination method were 95.36%, 95.21% and 95.80%, respectively. Both cytological and histological controls showed that human-machine coordination review method had higher diagnostic accuracy and sensitivity, and lower false negative rates. Conclusions: The artificial intelligence TPS assisted cytologic screening system has achieved acceptable accuracy in urine exfoliation cytologic screening. The combination of manual screening and artificial intelligence TPS assisted screening system can effectively improve the sensitivity and accuracy of cytologic screening and reduce the risk of misdiagnosis.
Humans
;
Artificial Intelligence
;
Urothelium/pathology*
;
Cytodiagnosis
;
Epithelial Cells/pathology*
;
Sensitivity and Specificity
;
Urologic Neoplasms/urine*
4.Diagnosis and treatment of urinary neurofibrosarcoma.
Zhou-Jun SHEN ; Yun-Xiao ZHOU ; Tian-Gao LIN ; Xiao-Dong JIN ; Song-Liang CAI
National Journal of Andrology 2005;11(6):455-457
OBJECTIVETo investigate the clinical characteristics, diagnosis and treatment of urinary neurofibrosarcoma.
METHODSClinical data of 1 case of urinary neurofibrosarcoma was analyzed retrospectively and related literature reviewed. The 61-year old male patient had undergone TURP for benign prostate hyperplasia ten months before.
RESULTSTotal urethral cavernostomy, total cystectomy and ileal cystostomy were performed on the patient and pathological diagnosis pointed to urinary neurofibrosarcoma. Another operation was done for metastatic rectal mass, which revealed abdominal metastasis. With progressing consumptive constitution, the patient died 40 days after the second operation.
CONCLUSIONIt is difficult to make a definite diagnosis in urinary neurofibrosarcoma, and the effective treatment for this highly malignant disease needs to be further studied.
Humans ; Male ; Middle Aged ; Neurofibrosarcoma ; diagnosis ; pathology ; surgery ; Retrospective Studies ; Urethral Neoplasms ; diagnosis ; pathology ; surgery ; Urologic Surgical Procedures ; methods
5.Epithelial neoplasms associated with osteoclast-like giant cells.
Yun-xiao MENG ; Ying JIANG ; Zhao-hui LU ; Jie CHEN
Chinese Journal of Pathology 2010;39(9):642-645
Adenocarcinoma, Mucinous
;
pathology
;
Breast Neoplasms
;
pathology
;
Carcinoma, Ductal, Breast
;
pathology
;
Carcinoma, Renal Cell
;
pathology
;
Carcinoma, Squamous Cell
;
pathology
;
Cystadenocarcinoma, Mucinous
;
pathology
;
Cystadenoma, Mucinous
;
pathology
;
Female
;
Giant Cells
;
pathology
;
Humans
;
Osteoclasts
;
pathology
;
Ovarian Neoplasms
;
pathology
;
Pancreatic Neoplasms
;
pathology
;
Thyroid Carcinoma, Anaplastic
;
Thyroid Neoplasms
;
pathology
;
Tongue Neoplasms
;
pathology
;
Urologic Neoplasms
;
pathology
6.Detection of bladder cancer using nuclear matrix protein proteomic marker NMP22.
Mesias Cecero U. ; de la Cruz Reynaldo C. ; de Guzman Rudolfo I.
Philippine Journal of Urology 2011;21(1):9-13
OBJECTIVE: To determine the validity of NMP-22 (Bladder Check Protein Test Pack Kit) in the diagnosis of bladder cancer.
MATERIALS: From May 1, 2009 to October 31, 2009 all patients with bladder mass by ultrasound, IVP or CT scan from three different urology training institutions were enrolled in this prospective study. These patients underwent urine cytology and NMP-22 qualitative assay. The diagnosis determined from the cytoscopic and histopathologic findings from CTURBT was accepted as the gold standard.
RESULTS: Thirty nine subjects were enrolled in this study, whom of 31 patients were diagnosed of malignancy and 8 were benign in pathology. The sensitivity of urine cytology, NMP-22 assay and cytoscopy was 34.6%, 96.8% and 92.3% respectively and the specificity was 37.5% for NMP-22 and 66.1% for the cytoscopy.
CONCLUSION: The result of this study suggests that NMP-22 is a very sensitive test, however is less specific in identifying bladder cancer.
Human ; Male ; Female ; Middle Aged ; Neoplasms ; Urologic Neoplasms ; Urinary Bladder Neoplasms-cytology, diagnosis, pathology ; nuclear matrix protein 22 ; ultrasonography ; Tomography Scanners, X-Ray Computed ; ;
7.A novel transurethral resection technique for superficial flat bladder tumor: Grasp and bite technique.
Kyung Jin OH ; Yoo Duk CHOI ; Ho Suck CHUNG ; Eu Chang HWANG ; Seung Il JUNG ; Dong Deuk KWON ; Kwangsung PARK ; Taek Won KANG
Korean Journal of Urology 2015;56(3):227-232
PURPOSE: Transurethral resection of bladder tumor (TURBT) can be a challenging procedure for an inexperienced surgeon. We suggest an easy technique for TURBT, which we have named the "grasp and bite" technique. We describe this technique and compare its effectiveness and safety with that of conventional TURBT. MATERIALS AND METHODS: Monopolar TURBT (24-Fr Karl Storz) was performed in 35 patients who had superficial bladder tumors. After defining the tumor margin, the tumor and surrounding mucosa were grasped by use of a loop electrode and resectoscope sheath. With tight grasping, linear moving resection was performed. The patients' demographic, intraoperative, and postoperative data were analyzed between the conventional and grasp and bite TURBT groups. RESULTS: Of 35 patients, 16 patients underwent conventional TURBT (group 1), and the other 19 patients underwent grasp and bite TURBT (group 2). Both groups were similar in age, tumor multiplicity, size, anesthesia method, and location. Grasp and bite TURBT could be performed as safely and effectively as conventional TURBT. There were no significant differences in irrigation duration, urethral catheterization, postoperative hemoglobin drop, or length of hospital stay. No significant side effects such as bladder perforation, severe obturator reflex, or persistent bleeding occurred. There were no significant pathological differences between specimens according to the type of resection technique. CONCLUSIONS: The grasp and bite TURBT technique was feasible for superficial bladder tumors. It may be a good tool for inexperienced surgeons owing to its convenient and easy manner.
Aged
;
Cystoscopy
;
Electrodes
;
Female
;
Humans
;
Male
;
Middle Aged
;
Postoperative Complications
;
Urinary Bladder/pathology/*surgery
;
Urinary Bladder Neoplasms/pathology/*surgery
;
Urologic Surgical Procedures/instrumentation/*methods
8.Inverted urothelial papilloma: report of 151 cases.
Qun WAN ; Jin-dan LUO ; Song-liang CAI ; Bo-hua SHEN ; Wei-ping ZHAO ; Zhi-gen ZHANG ; Li-ping XIE ; Zhou-jun SHEN
Chinese Journal of Surgery 2005;43(2):105-107
OBJECTIVETo investigate the clinical features, pathology, diagnosis and treatment of inverted urothelial papilloma.
METHODSA total of 151 cases of urothelial inverted papilloma were analysed retrospectively. Of the cases, 134 were male and 17 were female, with a mean age of 54 years old. Most patients complained of painless gross hematuria. The diagnosis could be established mainly by ultrasonic, intravenous urography, retrograde pyelography, cystoscope and pathology. Among them, 7 cases who had the papilloma at upper urinary tract underwent nephroureterectomy except one. One hundred and forty-four cases had the papilloma at low urinary tract, with 124 treated by transurethral bladder tumor resection (TURBT), among which 11 cases accompanying benign prostatic hyperplasia were treated by transurethral prostatic resection, 3 by transurethral resection of prostatic urethral tumor, 15 by partial cystectomy, 2 by total cystectomy.
RESULTSOne hundred and eighteen cases were followed up 1 year to 12.5 years (mean 6.3 years). Intravesical recurrence was found in 5 cases. Of them 2 cases developed malignance in 8 and 30 months postoperatively, and 1 case underwent total cystectomy.
CONCLUSIONSInverted urothelial papilloma is a benign tumor, which appears male predominant. Most of the lesions are found in the bladder. TURBT is the preferred treatment choice for inverted papilloma of the bladder. Although this disease has a good prognosis, regular follow-up observations are necessary.
Adult ; Aged ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Papilloma, Inverted ; diagnosis ; pathology ; surgery ; Retrospective Studies ; Urologic Neoplasms ; diagnosis ; pathology ; surgery
9.The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision.
Minyong KANG ; Chang Wook JEONG ; Cheol KWAK ; Hyeon Hoe KIM ; Ja Hyeon KU
Yonsei Medical Journal 2015;56(2):375-381
PURPOSE: To investigate oncological outcomes based on bladder cuff excision (BCE) during radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) and to provide clinical evidence of tumor recurrence in patients without BCE. MATERIALS AND METHODS: We retrospectively collected data of 372 consecutive patients who underwent RNU at our institution from May 1989 through October 2010. After excluding some data, we reviewed 336 patients for the analysis. RESULTS: Of the patients who underwent RNU with BCE (n=279, 83.0%) and without BCE (n=57, 17.0%), patients without BCE had poorer cancer-specific and overall survival rates. Among 57 patients without BCE, 35 (61.4%) experienced tumor recurrence. Recurrence at the remnant ureter resulted in poor oncological outcomes compared to those in patients with bladder recurrence, but better outcomes were observed compared to recurrence at other sites. No significant predictors for tumor recurrence at the remnant ureter were identified. In patients without BCE, pathological T stage [hazard ratio (HR), 5.73] and lymphovascular invasion (HR, 3.65) were independent predictors of cancer-specific survival, whereas age (HR, 1.04), pathological T stage (HR, 5.11), and positive tumor margin (HR, 6.50) were independent predictors of overall survival. CONCLUSION: Patients without BCE had poorer overall and cancer-specific survival after RNU than those with BCE. Most of these patients experienced tumor recurrence at the remnant ureter and other sites. Patients with non-organ confined UTUC after RNU without BCE may be considered for adjuvant chemotherapy with careful follow-up.
Adult
;
Aged
;
Carcinoma, Transitional Cell/*surgery
;
Chemotherapy, Adjuvant
;
Female
;
Humans
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local/*pathology
;
Nephrectomy/*methods
;
Retrospective Studies
;
Survival Rate
;
Treatment Outcome
;
Ureter/*surgery
;
Ureteral Neoplasms/*surgery
;
Urinary Bladder/pathology
;
Urinary Bladder Neoplasms/*pathology
;
Urologic Neoplasms/pathology/*surgery
;
*Urologic Surgical Procedures
;
Urothelium/*pathology
10.Correlation between adipokine and clinicopathological features and prognosis in upper tract urothelial carcinoma.
Xiang DAI ; Fei WANG ; Yi Qing DU ; Yu Xuan SONG ; Tao XU
Journal of Peking University(Health Sciences) 2022;54(4):605-614
OBJECTIVE:
To investigate the correlation between expression levels of adipokine and clinicopathological features and prognosis of patients with upper tract urothelial carcinoma (UTUC) based on immunohistochemical staining and bioinformatics analysis.
METHODS:
The 8 adipokines in this study included adiponectin (AdipoQ), leptin (LEP), interleukin (IL)-6, IL-10 and their receptors (AdipoR1, AdipoR2, LEPR, IL-6R, IL-10RA, IL-10RB). Tissue samples of patients with UTUC who underwent surgical treatment in Peking University People's Hospital from January 2014 to April 2021 were selected for immunohistochemical staining. Their quantitative gene expression data were calculated by H-Score, and relevant clinical and follow-up data were collected retrospectively. Transcription group sequencing data of UTUC patients in Gene Expression Omnibus database (GSE134292 dataset) were downloaded for comparison. Chi-square test or t-test was used to compare the expression level of adipokine between non-muscle invasive group and muscle invasive group. Univariate and multivariate Cox regression analysis and Kaplan-Meier survival curve were utilized to analyze independent predictors of overall survival (OS), disease-free survival (DFS), intravesical recurrence-free survival (IVRFS) in the both cohorts. The P < 0.05 was considered statistically significant.
RESULTS:
In the study, 63 tissue samples of the patients with UTUC who underwent surgical treatment in Peking University People's Hospital and 57 UTUC patients in GSE134292 dataset were selected. In immunohistochemical cohort, the expressions of AdipoQ (P=0.003 6), AdipoR1 (P=0.006 5), LEP (P=0.007 7), IL-10 (P=0.006 9), and IL-10RA (P=0.008 9) were statistically higher in muscle invasive group. In GSE134292 cohort, the expressions of AdipoR1 (P=0.000 4), AdipoR2 (P=0.000 4), IL-6 (P=0.005 0), IL-10 (P=0.001 7), and IL-10RA (P=0.008 1) were statistically higher in muscle invasive group. Kaplan-Meier survival curve and multivariate Cox regression analysis showed that high IL-10RA expression was an independent predictive factor of IVRFS (P=0.044, HR=0.996, 95%CI: 0.992-0.998) in immunohistochemical cohort, which was confirmed in GSE134292 cohort (P=0.014, HR=0.515, 95%CI: 0.304-0.873).
CONCLUSION
The expression levels of AdipoQ, AdipoR1, IL-10, and IL-10RA were correlated with tumor stage, suggesting that these adipokines played important roles in tumor progression. IL-10RA was an independent predictor of IVRFS, suggesting that IL-10 and its receptor played a critical role in tumor recurrence.
Adipokines
;
Carcinoma, Transitional Cell/surgery*
;
Humans
;
Interleukin-10
;
Neoplasm Recurrence, Local
;
Prognosis
;
Retrospective Studies
;
Urinary Bladder Neoplasms/surgery*
;
Urologic Neoplasms/pathology*